{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:03:13Z","timestamp":1787068993123,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.taap.2022.116003","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T11:01:25Z","timestamp":1648465285000},"page":"116003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Molnupiravir; molecular and functional descriptors of mitochondrial safety"],"prefix":"10.1016","volume":"442","author":[{"given":"K.B.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Bjork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.116003_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003030","article-title":"Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides","volume":"8","author":"Arnold","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.taap.2022.116003_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ab.2010.04.040","article-title":"A high-throughput respirometric assay for mitochondrial biogenesis and toxicity","volume":"404","author":"Beeson","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2022.116003_bb0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2022.116003_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfp093","article-title":"Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures","volume":"111","author":"Bjork","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2022.116003_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115783","article-title":"Remdesivir; molecular and functional measures of mitochondrial safety","volume":"433","author":"Bjork","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2022.116003_bb0030","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.taap.2022.116003_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618758524","article-title":"Addressing the selectivity and toxicity of antiviral nucleosides","volume":"26","author":"Feng","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.taap.2022.116003_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2017.04.005","article-title":"Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs","volume":"143","author":"Jin","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.taap.2022.116003_bb0045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.taap.2022.116003_bb0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","article-title":"Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity","volume":"22","author":"Kakuda","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.taap.2022.116003_bb0055","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116003_bb0060","first-page":"1610","article-title":"Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer","volume":"5","author":"Los","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2022.116003_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2011.06.067","article-title":"Mitochondrial DNA as a non-invasive biomarker: accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias","volume":"412","author":"Malik","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2022.116003_bb0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10863-012-9446-z","article-title":"Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform","volume":"44","author":"Nadanaciva","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.taap.2022.116003_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","article-title":"Roles of CHOP\/GADD153 in endoplasmic reticulum stress","volume":"11","author":"Oyadomari","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2022.116003_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02428-20","article-title":"Human safety, tolerability, and pharmacokinetics of Molnupiravir, a novel broad-Spectrum Oral antiviral agent with activity against SARS-CoV-2","volume":"65","author":"Painter","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2022.116003_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coviro.2019.04.002","article-title":"Nucleoside analogues for the treatment of coronavirus infections","volume":"35","author":"Pruijssers","year":"2019","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.taap.2022.116003_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2022.116003_bb0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2022.116003_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01719-19","article-title":"Analysis of the potential for N (4)-Hydroxycytidine to inhibit mitochondrial replication and function","volume":"64","author":"Sticher","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2022.116003_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fmolb.2017.00074","article-title":"Off-target effects of drugs that disrupt human mitochondrial DNA maintenance","volume":"4","author":"Young","year":"2017","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.taap.2022.116003_bb0110","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014885","article-title":"The antiretroviral 2\u2032,3\u2032-dideoxycytidine causes mitochondrial dysfunction in proliferating and differentiated HepaRG human cell cultures","volume":"296","author":"Young","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2022.116003_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jiab247","article-title":"beta-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells","volume":"224","author":"Zhou","year":"2021","journal-title":"J. Infect. Dis."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2200148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2200148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:58:15Z","timestamp":1758574695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2200148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":23,"alternative-id":["S0041008X2200148X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.116003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741884941.793592607","asserted-by":"object"}]},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molnupiravir; molecular and functional descriptors of mitochondrial safety","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.116003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116003"}}